These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29374651)

  • 1. Clarithromycin as a steroid sparing agent for the management of infantile bullous pemphigoid.
    Tso S; Petrof G; Unter S; Humphreys F
    BMJ Case Rep; 2018 Jan; 2018():. PubMed ID: 29374651
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of clarithromycin in a case of infantile bullous pemphigoid.
    Ghaoui N; Hamie L
    Pediatr Dermatol; 2024; 41(2):364-365. PubMed ID: 38205581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. British Association of Dermatologists' guidelines for the management of bullous pemphigoid 2012.
    Venning VA; Taghipour K; Mohd Mustapa MF; Highet AS; Kirtschig G
    Br J Dermatol; 2012 Dec; 167(6):1200-14. PubMed ID: 23121204
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful management of severe infant bullous pemphigoid with omalizumab.
    Dufour C; Souillet AL; Chaneliere C; Jouen F; Bodemer C; Jullien D; Cambazard F; Joly P; Reix P
    Br J Dermatol; 2012 May; 166(5):1140-2. PubMed ID: 22098309
    [No Abstract]   [Full Text] [Related]  

  • 5. Infantile pemphigoid treated without oral corticosteroids.
    Farrugia ME; Ball SL; Tidman MJ
    Clin Exp Dermatol; 2019 Oct; 44(7):832-833. PubMed ID: 31095751
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence-based management of bullous pemphigoid.
    Daniel BS; Borradori L; Hall RP; Murrell DF
    Dermatol Clin; 2011 Oct; 29(4):613-20. PubMed ID: 21925006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dupilumab for the Treatment of Recalcitrant Bullous Pemphigoid.
    Kaye A; Gordon SC; Deverapalli SC; Her MJ; Rosmarin D
    JAMA Dermatol; 2018 Oct; 154(10):1225-1226. PubMed ID: 30140849
    [No Abstract]   [Full Text] [Related]  

  • 8. Methotrexate for bullous pemphigoid: preliminary study.
    Bara C; Maillard H; Briand N; Celerier P
    Arch Dermatol; 2003 Nov; 139(11):1506-7. PubMed ID: 14623719
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjuvant therapy of bullous pemphigoid with mycophenolate mofetil: old drug, new use.
    Ratnam KV
    Singapore Med J; 2001 Oct; 42(10):482-4. PubMed ID: 11874153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current practice in treatment approach for bullous pemphigoid: comparison between national surveys from the Netherlands and the UK.
    Meijer JM; Jonkman MF; Wojnarowska F; Wiliams HC; Kirtschig G
    Clin Exp Dermatol; 2016 Jul; 41(5):506-9. PubMed ID: 26940484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of bullous pemphigoid with omalizumab.
    London VA; Kim GH; Fairley JA; Woodley DT
    Arch Dermatol; 2012 Nov; 148(11):1241-3. PubMed ID: 23165827
    [No Abstract]   [Full Text] [Related]  

  • 12. Survey of bullous pemphigoid in an Italian university hospital: clinical-epidemiological characteristics and follow-up.
    Balestri R; Odorici G; Patrizi A; Infusino SD; Magnano M; Bardazzi F
    G Ital Dermatol Venereol; 2018 Oct; 153(5):613-618. PubMed ID: 28079339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexistence of psoriasis and bullous pemphigoid: remission with low-dose methotrexate.
    Gunay U; Gunduz K; Ermertcan AT; Kandiloğlu AR
    Cutan Ocul Toxicol; 2013 Jun; 32(2):168-9. PubMed ID: 22429144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bullous pemphigoid associated with type 1 diabetes mellitus responsive to mycophenolate mofetil.
    Sakanoue M; Kawai K; Kanekura T
    J Dermatol; 2012 Oct; 39(10):884-5. PubMed ID: 22168231
    [No Abstract]   [Full Text] [Related]  

  • 15. Methotrexate is safe and efficient as long-term treatment for bullous pemphigoid.
    Delaumenie S; Assikar S; Prudhomme R; Matei I; Souyri N; Dalmay F; Bedane C
    Eur J Dermatol; 2019 Apr; 29(2):217-218. PubMed ID: 30734720
    [No Abstract]   [Full Text] [Related]  

  • 16. Autoimmune bullous eruption localized to a breast reconstruction site: response to niacinamide.
    Honl BA; Elston DM
    Cutis; 1998 Aug; 62(2):85-6. PubMed ID: 9714904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-laminin γ1 pemphigoid.
    Kalkoff EC; Bramsiepe I; Groth S; Marsch WC; Kreft B
    J Dtsch Dermatol Ges; 2013 Jun; 11(6):555-7. PubMed ID: 23480370
    [No Abstract]   [Full Text] [Related]  

  • 18. Bullous pemphigoid following therapy with an oral beta-blocker.
    Perry A; Sparling JD; Pennington M
    J Drugs Dermatol; 2005; 4(6):746-8. PubMed ID: 16302561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A successful treatment with ustekinumab in a case of relapsing bullous pemphigoid associated with psoriasis.
    Loget J; Plée J; Antonicelli F; Bernard P
    J Eur Acad Dermatol Venereol; 2017 May; 31(5):e228-e230. PubMed ID: 27730667
    [No Abstract]   [Full Text] [Related]  

  • 20. The approach of dermatologists in the UK to the treatment of bullous pemphigoid: results of a national survey.
    Taghipour K; Mohd Mustapa MF; Highet AS; Venning VA; Kirtschig G
    Clin Exp Dermatol; 2013 Apr; 38(3):311-3. PubMed ID: 23517364
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.